MOUNTAIN VIEW, Calif. (January 14, 2014) – Amaranth Medical, a privately held medical device company,
today announced the closing of an equity investment by Boston Scientific Corporation (NYSE: BSX). The
additional investment capital will be used to advance the clinical development of the Amaranth FORTITUDE™
drug eluting bioresorbable scaffold in a planned international clinical study and subsequent application for CE
Mark.

One of the largest medical device financings of the past year in the US; funds will support
multiple clinical trials, including recently expanded US pivotal trial for novel glaucoma device

WATERTOWN, Mass. – January 9, 2014 – FORMA Therapeutics announced today the achievement of
several discovery milestones in their alliance with Boehringer Ingelheim (BI) for the discovery of novel
drug candidates against protein-protein interactions (PPI) for the treatment of cancer.

A pair of small biotechs with big dreams made it under the wire
to end 2013 with the last IPO pitches of the year. Revance
Therapeutics filed for an $86 million IPO to back its next-gen
version of Botox, with Dicerna Therapeutics stepping up on the
last day of the year with a $69 million offering as it prepped its
first trial.

【2013 年 12 月 20 日】在近日召开的第六届漏洞分析不风险评估大会上，中国信息
安全测评中心举行了中国国家信息安全漏洞库（CNNVD）技术支撑单位的授牌仪式不特聘
与家证书颁发仪式。网站安全与家安全宝成为首批国家漏洞库支撑单位，并领取了授权牌。

MOUNTAIN VIEW, Calif. (December 11, 2013) — Ooyala, the leading innovator in video streaming,
analytics and monetization, today announced it received a USD $43 million investment from Telstra,
Australia’s largest telecommunications company.

Singapore, 11th December 2012 – MerLion Pharmaceuticals (MerLion) announced today
that it has initiated the first Phase II clinical trial using intravenous (iv) and oral formulations
of finafloxacin to treat patients requiring hospitalisation with complicated urinary tract
infections and pyelonephritis.

SAN DIEGO – October 10, 2013 – Sotera® Wireless, Inc. today announced the U.S. Food and
Drug Administration has cleared the Company’s patented continuous non-invasive blood
pressure (cNIBP) technology, a new feature of the ViSi Mobile® wireless patient monitoring
system.

Singapore – October 8, 2013 – Amaranth Medical, a privately-held medical device company,
announced the closing of a US $20 million Series B financing led by new investor DCP Management of
Singapore. Existing investors Bio*One Capital, Charter Life Sciences and Phillip Capital, as well as new
investor Venstar Capital, also participated in the financing.

Boston, MA – Oct. 3, 2013 – RAMP, the industry’s leading provider of next generation
video and search experiences for media and enterprises, today announced that it has been
named to the 2013 Streaming Media 100 for the second year running.